2020
DOI: 10.1155/2020/8730471
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Absorption and Scattering on Fluorescence of Buried Tumours

Abstract: Fluorescence spectroscopy is widely used for biomedical optical diagnosis and surgical resection of tumours. is work investigates laserinduced fluorescence spectroscopy of fluorescence inclusions that are embedded in turbid media. 405 nm laser diode is used for exciting buried protoporphyrin-(PpIX) based inclusions in brain-like optical phantoms. Effects of scattering and absorption of the turbid medium on the recorded fluorescence signal and depth-resolved fluorescence were studied. Results show that optical … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 22 publications
0
1
0
Order By: Relevance
“…A key factor limiting the adoption of existing molecular probes in clinical practice is their use with conventional PET and fluorescence intensity imaging, which cannot readily distinguish tumor-specific from the nonspecific probes in tissue ( 31 , 32 ). Furthermore, intensity-based measures are system-dependent, and can be affected by tissue properties ( 33 , 34 ) and measurement conditions, making comparisons across multiple subjects across trials or the same subject over time difficult. This is particularly relevant for immune biomarkers (e.g., PD-L1) due to their dynamic and heterogeneous expression profiles in the baseline and during treatment.…”
Section: Introductionmentioning
confidence: 99%
“…A key factor limiting the adoption of existing molecular probes in clinical practice is their use with conventional PET and fluorescence intensity imaging, which cannot readily distinguish tumor-specific from the nonspecific probes in tissue ( 31 , 32 ). Furthermore, intensity-based measures are system-dependent, and can be affected by tissue properties ( 33 , 34 ) and measurement conditions, making comparisons across multiple subjects across trials or the same subject over time difficult. This is particularly relevant for immune biomarkers (e.g., PD-L1) due to their dynamic and heterogeneous expression profiles in the baseline and during treatment.…”
Section: Introductionmentioning
confidence: 99%